SCMP BusinessAI 繁中編譯10/10 08:00 (HKT)
中國力爭2030年前培育5款收益達10億美元的創新藥 會是哪些?

中國企業研發的新型療法在全球吸引力日增,推動中國崛起成為生物醫藥強國,惟中國至今仍未有一款藥物的銷售額足以媲美西方史上最暢銷的重磅藥。北京已定下進取的全新五年目標,以提升其在全球的生物醫藥地位,
由 AI 自動翻譯自英文原文(保留香港新聞術語規範)
英文原標題:China wants 5 innovative drugs with US$1 billion returns by 2030. Which might they be?
英文原摘要:The increasing global appeal of Chinese firms’ novel therapies has propelled the country’s rise as a biomedical powerhouse, but China has yet to produce a drug to rival all-time best-selling Western blockbusters in sales. Beijing has set ambitious new five-year targets to boost its global presence,